Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (171-180 of 500) with videos related to

Pageof 50
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patientsJoel Y Sun, Andrew Dagis, Laima Gaidulis, et al.
Stem Cell Research & Therapy|April 19, 2023
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective studyDat Ngo, Jason Chen, Jose Tinajero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal StudyNoha Sharafeldin, Alysia Bosworth, Sunita K Patel, et al.
British Journal of Haematology|August 24, 2019
Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemiaIbrahim Aldoss, Jianying Zhang, Raju Pillai, et al.
Blood Advances|August 30, 2021
Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk modelRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Bone Marrow Transplantation|October 17, 2019
Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantationKristen Mascarenhas, Jennifer Berano Teh, Kelly Peng, et al.
The Journal of Infectious Diseases|February 18, 2005
Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipientsSimon F Lacey, Joy Martinez, Ghislaine Gallez-Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Clinical and Genetic Risk Prediction of Cognitive Impairment After Blood or Marrow Transplantation for Hematologic MalignancyNoha Sharafeldin, Joshua Richman, Alysia Bosworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell TransplantationEllen K Chang, Dayana Chanson, Jennifer Berano Teh, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2020
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditionsZhenyuan Dong, Wesley A Cheng, D Lynne Smith, et al.
Pageof 50

Showing results (171-180 of 500) with videos related to

Sort By:
Pageof 50
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patientsJoel Y Sun, Andrew Dagis, Laima Gaidulis, et al.
Stem Cell Research & Therapy|April 19, 2023
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective studyDat Ngo, Jason Chen, Jose Tinajero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal StudyNoha Sharafeldin, Alysia Bosworth, Sunita K Patel, et al.
British Journal of Haematology|August 24, 2019
Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemiaIbrahim Aldoss, Jianying Zhang, Raju Pillai, et al.
Blood Advances|August 30, 2021
Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk modelRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Bone Marrow Transplantation|October 17, 2019
Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantationKristen Mascarenhas, Jennifer Berano Teh, Kelly Peng, et al.
The Journal of Infectious Diseases|February 18, 2005
Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipientsSimon F Lacey, Joy Martinez, Ghislaine Gallez-Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Clinical and Genetic Risk Prediction of Cognitive Impairment After Blood or Marrow Transplantation for Hematologic MalignancyNoha Sharafeldin, Joshua Richman, Alysia Bosworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell TransplantationEllen K Chang, Dayana Chanson, Jennifer Berano Teh, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2020
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditionsZhenyuan Dong, Wesley A Cheng, D Lynne Smith, et al.
Pageof 50